Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.
Coherus Biosciences has raised $50.1M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2026.
Coherus Biosciences's investors include RA Capital Management, Vivo Capital, Venrock, Sofinnova Investments, Eight Roads Ventures.
Coherus Biosciences is headquartered in Redwood City, United States.
Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.
Coherus Biosciences is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Coherus Biosciences — Funding & Investors." VCBacked, February 12, 2026, https://www.vcbacked.co/company/coherus-biosciences. Accessed July 19, 2026.
VCBacked. (2026). Coherus Biosciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/coherus-biosciences
{{cite web |title=Coherus Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/coherus-biosciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated